 The IPO of OKYO Pharma Limited will take place on 15 December on the NASDAQ exchange. The company is engaged in the development of drugs for the treatment of ophthalmic diseases. We take a closer look at OKYO Pharma Limiteds business and financial position. The post OKYO Pharma IPO: Innovative Treatment for Xerophthalmia appeared first at R Blog - RoboForex... 